Contact Us
Nabi-HB Global Market Report 2025
Global Nabi HB Market Report 2025
Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Nabi-HB Global Market Report 2025

By Indication (Post-Exposure Prophylaxis, Prevention in High-Risk Populations), By Formulation (Injectable Solution, Pre-Filled Syringes), By Distribution Channel (Hospitals, Specialty Clinics, Public Health Agencies, Pharmacies), By End User Patients (Infants, Adult Patients)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Nabi-HB Market?

Nabi-HB is a human hepatitis B immune globulin (HBIG) used for post-exposure prophylaxis of hepatitis B virus (HBV) infection, particularly in individuals who have been exposed to the virus through needlesticks, surgery, or other forms of contact. It provides passive immunity by supplying antibodies against the HBV, offering temporary protection against infection until the body produces its own immune response.

The main types of indications for nabi-hb include post-exposure prophylaxis and prevention in high-risk populations. Post-exposure prophylaxis refers to the administration of preventive treatment after potential exposure to a disease, such as hepatitis B, to reduce the likelihood of infection. It is available as an injectable solution and pre-filled syringes and is distributed through Hospitals, specialty clinics, public health agencies, and pharmacies. It is used by infants and adult patients.

Nabi-HB Market Size and growth rate 2025 to 2029: Graph

What Is The Nabi-HB Market Size 2025 And Growth Rate?

The nabi-hb market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to reliable supply chains, international health policies, government programs promoting HBV prevention, inclusion in clinical practice guidelines, and increasing insurance coverage.

What Is The Nabi-HB Market Growth Forecast?

The nabi-HB market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the prevalence of hepatitis B virus (HBV) infections, awareness of post-exposure prophylaxis, availability of healthcare facilities, support from advocacy groups, and an increasing aging population. Major trends in the forecast period include the availability of HBV vaccines, regulatory approvals and guidelines, advancements in biotechnology, shifts towards preventive medicine, and advancements in medical research.

Customer representative image Book your 30 minutes free consultation with our research experts

How Is The Nabi-HB Market Segmented?

The nabi-hb market covered in this report is segmented –

1) By Indication: Post-Exposure Prophylaxis; Prevention in High-Risk Populations

2) By Formulation: Injectable Solution; Pre-Filled Syringes

3) By Distribution Channel: Hospitals; Specialty Clinics; Public Health Agencies; Pharmacies

4) By End User Patients: Infants; Adult Patients

What Is Driving The Nabi-HB Market? Rising Hepatitis B Prevalence And Its Impact On Global Health

The increasing prevalence of hepatitis B is expected to propel the growth of the nabi-hb market going forward. Hepatitis B is a serious liver infection caused by the hepatitis B virus (HBV), which can lead to chronic liver diseases and liver cancer. Hepatitis B cases are rising due to factors such as insufficient vaccination coverage, increased unprotected sexual activity, sharing of needles among drug users, and inadequate access to healthcare in high-risk regions. Nabi-HB plays a crucial role in providing immediate, short-term protection against hepatitis B, especially in high-risk scenarios such as post-exposure prophylaxis and during liver transplants. For instance, in April 2024, according to the World Health Organization (WHO), an estimated 254 million people were living with chronic hepatitis B infection in 2022, with 1.2 million new infections each year. Additionally, hepatitis B resulted in approximately 1.1 million deaths globally in 2022. Therefore, the increasing prevalence of hepatitis B is driving the growth of the nabi-hb market.

What Is Driving The Nabi-HB Market? Impact Of Rising Chronic Diseases On The Growth Of The Market

The rise in chronic diseases is expected to propel the growth of the nabi-hb market going forward. Chronic diseases are long-term medical conditions that typically require ongoing management, including treatment and preventive care. Chronic diseases are rising due to factors such as aging populations, unhealthy lifestyles (including poor diet, lack of physical activity, and smoking), environmental factors, and increased exposure to risk factors like pollution and stress. Nabi-HB helps chronic diseases by providing passive immunity against hepatitis B virus (HBV), particularly in individuals who are at high risk of exposure, thereby preventing the development of chronic HBV infection and its long-term complications such as liver cirrhosis or liver cancer, which are common among those with chronic viral infections. For instance, in October 2024, according to Liver Cancer UK, a UK-based health charity, new cases of liver cancer increased by 8,085 in 2022, with 4,700 cases in males and 3,385 cases in females. Therefore, the rise in chronic diseases is a key driver of the nabi-hb market.

What Is Driving The Nabi-HB Market? Growth Of The Market Driven By The Rising Aging Population

The rise in the aging population is expected to propel the growth of the nabi-hb market going forward. An aging population refers to a demographic trend where the proportion of individuals aged 65 and older increases within a population, often due to longer life expectancy and lower birth rates. The aging population is rising due to advancements in healthcare, improved living standards, and increased life expectancy, coupled with declining birth rates. Nabi-HB helps the aging population by providing passive immunity against the hepatitis B virus, reducing the risk of chronic infections and their complications, which are more prevalent in older adults due to weakened immune systems and increased exposure to viral infections, ultimately supporting healthier aging and reducing long-term healthcare costs. For instance, in October 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, one in six people worldwide will be 60 years or older by 2030, with the population in this age group rising from 1 billion in 2020 to 1.4 billion. By 2050, the global population of individuals aged 60 and above is expected to double, reaching 2.1 billion. Additionally, the number of people aged 80 or older is projected to triple between 2020 and 2050, reaching 426 million. Therefore, the rise in the aging population is driving the growth of the nabi-hb market.

Who Are The Major Players In The Global Nabi-HB Market?

Major companies operating in the nabi-hb market are ADMA Biologics Inc.

Need data on a specific region in this market?

Regional Analysis For The Global Nabi-HB Market

North America was the largest region in the nabi-hb market in 2024. The regions covered in the nabi-hb market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nabi-hb market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Nabi-HB Market?

The nabi-hb market consists of sales of combination vaccines, immunoglobulins, flu vaccines and pneumococcal vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Nabi-HB Industry?

The nabi-hb market research report is one of a series of new reports from The Business Research Company that provides nabi-hb market statistics, including nabi-hb industry global market size, regional shares, competitors with a nabi-hb market share, detailed nabi-hb market segments, market trends and opportunities, and any further data you may need to thrive in the nabi-hb industry. This nabi-hb market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Author : Abhilash Pyata

Nabi HB Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The nabi-hb market covered in this report is segmented –
1) By Indication: Post-Exposure Prophylaxis; Prevention in High-Risk Populations
2) By Formulation: Injectable Solution; Pre-Filled Syringes
3) By Distribution Channel: Hospitals; Specialty Clinics; Public Health Agencies; Pharmacies
4) By End User Patients: Infants; Adult Patients
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled ADMA Biologics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Nabi-HB Market Characteristics

3. Nabi-HB Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Nabi-HB Market Trends And Strategies

5. Nabi-HB Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Nabi-HB Growth Analysis And Strategic Analysis Framework

6.1. Global Nabi-HB PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Nabi-HB Market Growth Rate Analysis

6.4. Global Nabi-HB Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Nabi-HB Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Nabi-HB Total Addressable Market (TAM)

7. Global Nabi-HB Pricing Analysis & Forecasts

8. Nabi-HB Market Segmentation

8.1. Global Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Post-Exposure Prophylaxis

Prevention in High-Risk Populations

8.2. Global Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Injectable Solution

Pre-Filled Syringes

8.3. Global Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospitals

Specialty Clinics

Public Health Agencies

Pharmacies

8.4. Global Nabi-HB Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Infants

Adult Patients

9. Global Nabi-HB Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Nabi-HB Market Regional And Country Analysis

10.1. Global Nabi-HB Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Nabi-HB Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Nabi-HB Market

11.1. Asia-Pacific Nabi-HB Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Nabi-HB Market

12.1. China Nabi-HB Market Overview

12.2. China Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Nabi-HB Market

13.1. India Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Nabi-HB Market

14.1. Japan Nabi-HB Market Overview

14.2. Japan Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Nabi-HB Market

15.1. Australia Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Nabi-HB Market

16.1. South Korea Nabi-HB Market Overview

16.2. South Korea Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Nabi-HB Market

17.1. Western Europe Nabi-HB Market Overview

17.2. Western Europe Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Nabi-HB Market

18.1. UK Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Nabi-HB Market

19.1. Germany Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Nabi-HB Market

20.1. France Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Nabi-HB Market

21.1. Eastern Europe Nabi-HB Market Overview

21.2. Eastern Europe Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Nabi-HB Market

22.1. North America Nabi-HB Market Overview

22.2. North America Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Nabi-HB Market

23.1. USA Nabi-HB Market Overview

23.2. USA Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Nabi-HB Market

24.1. Canada Nabi-HB Market Overview

24.2. Canada Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Nabi-HB Market

25.1. South America Nabi-HB Market Overview

25.2. South America Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Nabi-HB Market

26.1. Middle East Nabi-HB Market Overview

26.2. Middle East Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Nabi-HB Market

27.1. Africa Nabi-HB Market Overview

27.2. Africa Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Nabi-HB Market Competitive Landscape And Company Profiles

28.1. Nabi-HB Market Competitive Landscape

28.2. Nabi-HB Market Company Profiles

28.2.1. ADMA Biologics Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Nabi-HB Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Nabi-HB Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Nabi-HB Market

32. Recent Developments In The Nabi-HB Market

33. Nabi-HB Market High Potential Countries, Segments and Strategies

33.1 Nabi-HB Market In 2029 - Countries Offering Most New Opportunities

33.2 Nabi-HB Market In 2029 - Segments Offering Most New Opportunities

33.3 Nabi-HB Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Nabi-HB Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Nabi-HB Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Global Nabi-HB Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: Asia-Pacific, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: China, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: India, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Japan, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: Australia, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: South Korea, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: Western Europe, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: UK, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: Germany, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: France, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: Eastern Europe, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: North America, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: USA, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: Canada, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: South America, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Middle East, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Africa, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 60: ADMA Biologics Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Nabi-HB Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Nabi-HB Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Global Nabi-HB Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: Asia-Pacific, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: China, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: India, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Japan, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: Australia, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: South Korea, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: Western Europe, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: UK, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: Germany, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: France, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: Eastern Europe, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: North America, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: USA, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: Canada, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: South America, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Middle East, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Nabi-HB Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Nabi-HB Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Africa, Nabi-HB Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 60: ADMA Biologics Inc. Financial Performance

Frequently Asked Questions

Nabi-HB is a human hepatitis B immune globulin (HBIG) used for post-exposure prophylaxis of hepatitis B virus (HBV) infection, particularly in individuals who have been exposed to the virus through needlesticks, surgery, or other forms of contact. It provides passive immunity by supplying antibodies against the HBV, offering temporary protection against infection until the body produces its own immune response. For further insights on the Nabi-HB market, request a sample here

The Nabi-HB market major growth driver - Rising Hepatitis B Prevalence And Its Impact On Global Health. For further insights on the Nabi-HB market, request a sample here

The Nabi-HB market size has grown strongly in recent years. The nabi-hb market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to reliable supply chains, international health policies, government programs promoting HBV prevention, inclusion in clinical practice guidelines, and increasing insurance coverage. The nabi-HB market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the prevalence of hepatitis B virus (HBV) infections, awareness of post-exposure prophylaxis, availability of healthcare facilities, support from advocacy groups, and an increasing aging population. Major trends in the forecast period include the availability of HBV vaccines, regulatory approvals and guidelines, advancements in biotechnology, shifts towards preventive medicine, and advancements in medical research. For further insights on the Nabi-HB market, request a sample here

The nabi-hb market covered in this report is segmented –
1) By Indication: Post-Exposure Prophylaxis; Prevention in High-Risk Populations
2) By Formulation: Injectable Solution; Pre-Filled Syringes
3) By Distribution Channel: Hospitals; Specialty Clinics; Public Health Agencies; Pharmacies
4) By End User Patients: Infants; Adult Patients For further insights on the Nabi-HB market,
request a sample here

North America was the largest region in the nabi-hb market in 2024. The regions covered in the nabi-hb market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Nabi-HB market, request a sample here.

Major companies operating in the nabi-hb market are ADMA Biologics Inc. . For further insights on the Nabi-HB market, request a sample here.

Major trends in the Nabi-HB market include . For further insights on the Nabi-HB market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon